Company / PP&E per Share
Spyre Therapeutics, Inc. PP&E per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
-
FY2023
5-year range
$0.00 / $0.09
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
#192 of 191
Health Care
What the data says
Declined from $0.09 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -1% in Health CareTop 101% of 191
▼
Key checks
Key Insights
- Spyre Therapeutics, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2023, pp&e per share decreased 100.0% year-over-year.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.07 | -31.2% |
| FY2021 | $0.09 | -51.1% |
| FY2020 | $0.19 | +96.3% |
| FY2019 | $0.10 | +61.8% |
| FY2018 | $0.06 | +8.2% |
| FY2017 | $0.06 | -7.7% |
| FY2016 | $0.06 | -89.5% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026